The OCEAN Trial found that rivaroxaban did not significantly reduce the incidence of stroke, systemic embolism, or new covert embolic events compared with aspirin in patients at high risk for stroke ...

In an effort to clearly understand the state of cardiovascular health in the U.S., the inaugural JACC Cardiovascular Statistics 2026 report offers a comprehensive picture of the major cardiovascular ...

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke ...

More time spent sitting, reclining or lying down during the day may increase the risk of cardiovascular disease (CVD) and death, according to a study in JACC, the flagship journal of the American ...

The researchers used data from the 2020 U.S. Census Bureau report for the years 2025 to 2060, and combined these census counts with the prevalence of cardiovascular risk factors or disease based on ...

From coffee to tea, caffeinated beverages are an integral part of morning routines across the globe, but these popular drinks can be harmful when enjoyed in excess. According to a new study being ...

A world without cardiovascular disease (CVD) is possible, yet millions of lives are lost prematurely to heart disease each year, according to the new Global Burden of Disease (GBD) special report ...

A new ACC Scientific Statement on Inflammation and Cardiovascular Disease (CVD) highlights new groundbreaking research linking inflammation atherosclerotic cardiovascular disease (ASCVD) and provides ...

Cardiovascular diseases (CVD) remain the leading cause of disease burden , causing one in three deaths worldwide as a result of population growth, population aging and exposure to a broad range of ...

Oral semaglutide 25 mg once daily was associated with significant weight loss vs. placebo, comparable with that seen with the 50 mg oral dose and with the subcutaneous (SC) injectable version of the ...

Marijuana is now legal in many places, but is it safe? Two new studies add to mounting evidence that people who use cannabis are more likely to suffer a heart attack than people who do not use the ...

The latest Clinical Practice Guideline from the ACC, the AHA and 11 other societies provides updated recommendations for clinicians on the prevention, detection, evaluation and management of high ...